🔎 Trials Near Me

Home › Degenerative Nerve Diseases › Massachusetts › Boston

Degenerative Nerve Diseases clinical trials in Boston, MA

5 studies for Degenerative Nerve Diseases are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

RecruitingPhase 2
  • Massachusetts General Hospital - Charlestown, Charlestown · 1 mi away
Ages 55 to 85 · All sexes · Updated Nov 4, 2026 · NCT07589595

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

RecruitingPhase 1
  • Massachusetts General Hospital (MGH), Charlestown · 1 mi away
Ages 50 to 85 · All sexes · Updated Oct 29, 2026 · NCT06297590

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

RecruitingPhase 1/2
  • Massachusetts General Hospital /ID# 270960, Boston
6 Months · All sexes · Updated Oct 19, 2026 · NCT05757141

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

RecruitingObservational studyHealthy volunteers welcome
  • Boston University, Boston
  • Massachusetts General Hospital, Boston
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

RecruitingObservational study
  • Boston Children's Hospital, Boston
1 Month – 30 Years · All sexes · Updated Mar 18, 2026 · NCT05354622

About Degenerative Nerve Diseases

Degenerative nerve diseases, or neurodegenerative diseases, are disorders that destroy cells in your nervous system. Learn about the types and treatments.

More about Degenerative Nerve Diseases on MedlinePlus

Degenerative Nerve Diseases trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.